维普期刊资源整合服务平台（V6.5）

90篇 您的检索式：作者名="Socinski M"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Efficacy and safety of sunitinib in previously treated,advanced non-small cell lung cancer (NSCLC):Preliminary results of a multicenter phase Ⅱ trial显示文摘	Socinski M A Novello S Sanchez J M	2006	J Clin Oncol2006，24，18：	1
2	Clinical issues in the management of non -small - cell lung cancer and the role of platinum - based therapy显示文摘	Socinski M A	2004	Clin Lung Cancer2004，5，5：	1
3	Multitargeted receptor tyrosine kinase inhibition:an antiangiogenic strategy in nonsmall cell lung cancer显示文摘	SOCINSKI M A	2011	Cancer Treat Rev2011，37，8：	1
4	Multicenter,phase II trail of sunitlnib in previously treated, advanced non-small-cell lung cancer显示文摘	Socinski M A Novello S Brahmer J R	2008	J Clin Oncol2008，26，：	1
5	Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage Ⅲ A and Ⅲ B non-small-cell lung cancer: a dose-escalation phase 1 trial 显示文摘	Socinski M A Morris D E Halle J S	2004	J Clin Oncol2004，22，21：	1
6	Current treatment for advanced stage non-small-cell lung cancer显示文摘	Stichocombe T E Socinski M A	2009	Proc Am Thorac Soc2009，6，2：	1
7	Phase III study of pemetrexed plus carboplatin compared with eto- poside plus earboplatin in chemotherapy - naive patients with extensive - stage small - cell lung cancer 显示文摘	Smit E F Lorigan P Socinski M A	2009	J Clin Oncol2009，27，28：	1
8	Weekly nab- paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer:final results of a phase III trial显示文摘	Socinski M A Bondarenko I Karaseva N A	2012	J Clin Oncol2012，30，17：	1
9	Phase EI trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/ IV non-small cell lung cancer显示文摘	SOCINSKI MA SCHELL M J PETERMAN A	2002	J Clin Oncol2002，20，5：	1
10	Randomized phase II trial of pemetrexed combined with either cisplatin or arboplatin in untreated extensive-stage small-lung cancer显示文摘	Socinski M Weissman C Hart L	2006	Proc Am Soc Clin Oncol2006，24，30：	1
11	Induction and concurrent carboplatin/paclitaxel with dose - eecalated thoracic conformal radiotherapy in stage Ⅲ A/Ⅲ B non - small cell lung cancer: a phase Ⅰ/Ⅱ trial显示文摘	Halle J Schel1 M etal	2000	Proc Amosoc Clin Oncol USA2000，19，：	1
12	Resuhs of a randomized, phase Ⅲ trial of nab paclitaxel (nab P) and carhoplatin (C) compared with cremophor-based paclitaxel (P) and carboplatin as first line therapy in advanced non small cell lung cancer (NSCLC)显示文摘	Socinski M A Bondarenko I N Karaseva N A	2010	J Clin Oncol2010，98，18：	1
13	Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines (2nd edition) 显示文摘	Socinski M A Crowell R Hensing T E	2007	Chest2007，132，3：	1
14	Evidence-based medicine in the treatment of non-small cell lung cancer显示文摘	Reif M Socinski MA Rivera MP	2009	Clin Chest Med2009，21，1：	1
15	Phase Ⅲ trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced stage Ⅲ B/Ⅳ non-small cell lung cancer显示文摘	Socinski M A Schell M J Peterman A	2002	J Clin Oncol2002，20，5：	1
16	Maintenance therapy in advanced non-small cell lung cancer: current status and future implications显示文摘	Stinchcombe T E Socinski M A	2011	J Thorac Oncol2011，6，1：	1
17	1 Third genera- tion chemotherapy regimens (3GR) improve survival over second generation regimens (2GR) in stagel]I B/IV non-small cell lung cancer (NSCLC): a meta-analysis of the published literature显示文摘	Baggstrom M Socinski MA Hensing T eta	2002	Proc Am Soc Clin Oncol2002，21，3：	1
18	Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naive advanced non-small cell lung cancer 显示文摘	LANGER C J OBYRNE K J SOCINSKI M A	2008	J Thorac Oncol2008，3，6：	1
19	Results of a randomized,phase Ⅲ trial of nab-paclitaxel (nabP) and carboplatin (C) compared with cremophor-based paclitaxel (P) and carboplatin as first-line therapy in advanced non-small cell lung cancer (NSCLC)显示文摘	Socinski M A Bondarenko I N Karaseva N A		0，，18：	1
20	Limited-stage small-cell lung cancer: the current status of combined-modality therapy显示文摘	Socinski M A Bogart J A	2007	J Clin Oncol2007，25，26：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示